JP2001502297A - 医薬用化合物 - Google Patents
医薬用化合物Info
- Publication number
- JP2001502297A JP2001502297A JP10511080A JP51108098A JP2001502297A JP 2001502297 A JP2001502297 A JP 2001502297A JP 10511080 A JP10511080 A JP 10511080A JP 51108098 A JP51108098 A JP 51108098A JP 2001502297 A JP2001502297 A JP 2001502297A
- Authority
- JP
- Japan
- Prior art keywords
- group
- compound
- alkyl
- hydrogen
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D273/00—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US1996/013855 WO1997007798A1 (en) | 1995-08-30 | 1996-08-30 | Pharmaceutical compounds |
US3898997P | 1997-02-26 | 1997-02-26 | |
US60/038,989 | 1997-02-26 | ||
US3952997P | 1997-03-03 | 1997-03-03 | |
US96/13855 | 1997-03-03 | ||
US60/039,529 | 1997-03-03 | ||
PCT/US1997/015245 WO1998008506A1 (en) | 1996-08-30 | 1997-08-29 | Pharmaceutical compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2001502297A true JP2001502297A (ja) | 2001-02-20 |
Family
ID=27365489
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP10511080A Pending JP2001502297A (ja) | 1996-08-30 | 1997-08-29 | 医薬用化合物 |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0957912A1 (zh) |
JP (1) | JP2001502297A (zh) |
AU (1) | AU4330097A (zh) |
CA (1) | CA2263420A1 (zh) |
WO (1) | WO1998008506A1 (zh) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0869786B1 (en) * | 1995-12-22 | 2003-03-05 | Eli Lilly And Company | Pharmaceutical compounds |
JP2001500484A (ja) * | 1996-08-30 | 2001-01-16 | イーライ・リリー・アンド・カンパニー | 医薬化合物の製造法 |
EP0929556A4 (en) * | 1996-09-06 | 2001-04-18 | Lilly Co Eli | PROCESS AND NEW INTERMEDIATES |
WO1998009988A1 (en) * | 1996-09-06 | 1998-03-12 | Eli Lilly And Company | Process to prepare pharmaceutical compounds |
JP2001513775A (ja) * | 1997-02-26 | 2001-09-04 | イーライ・リリー・アンド・カンパニー | トリペプチドおよびテトラペプチド医薬化合物 |
EA002547B1 (ru) * | 1997-02-26 | 2002-06-27 | Эли Лилли Энд Компани | Способ селективного эпоксидирования для получения лекарственных соединений |
US6180679B1 (en) * | 1998-04-07 | 2001-01-30 | Eli Lilly And Company | Method for treating fungal infections |
US6103913A (en) * | 1998-10-16 | 2000-08-15 | Eli Lilly And Company | Process for preparing enollactone derivatives |
US6376230B1 (en) | 1998-10-16 | 2002-04-23 | Eli Lilly And Company | Stereoselective process for producing intermediates of cryptophycins |
US7303749B1 (en) | 1999-10-01 | 2007-12-04 | Immunogen Inc. | Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents |
EP2289549A3 (en) | 1999-10-01 | 2011-06-15 | Immunogen, Inc. | Immunoconjugates for treating cancer |
JP2006516275A (ja) * | 2003-01-22 | 2006-06-29 | ワーナー−ランバート カンパニー リミティド ライアビリティー カンパニー | シクロプロピルβ−アミノ酸誘導体 |
US8088387B2 (en) | 2003-10-10 | 2012-01-03 | Immunogen Inc. | Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates, and methods of making said conjugates |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69427706T2 (de) * | 1993-12-21 | 2001-10-25 | Univ Hawaii Honolulu | Cryptophycine |
JP2000501067A (ja) * | 1995-08-30 | 2000-02-02 | イーライ・リリー・アンド・カンパニー | 医薬化合物 |
ATE201018T1 (de) * | 1996-02-27 | 2001-05-15 | Lilly Co Eli | Cryptophycinderivate und ihre verwendung als antimikrotubuli mittel |
-
1997
- 1997-08-29 AU AU43300/97A patent/AU4330097A/en not_active Abandoned
- 1997-08-29 JP JP10511080A patent/JP2001502297A/ja active Pending
- 1997-08-29 WO PCT/US1997/015245 patent/WO1998008506A1/en not_active Application Discontinuation
- 1997-08-29 CA CA002263420A patent/CA2263420A1/en not_active Abandoned
- 1997-08-29 EP EP97941379A patent/EP0957912A1/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
EP0957912A1 (en) | 1999-11-24 |
WO1998008506A1 (en) | 1998-03-05 |
CA2263420A1 (en) | 1998-03-05 |
EP0957912A4 (zh) | 1999-12-22 |
AU4330097A (en) | 1998-03-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2000501067A (ja) | 医薬化合物 | |
JP4364944B2 (ja) | 医薬化合物群 | |
RU2669805C2 (ru) | (6s,9as)-n-бензил-6-[(4-гидроксифенил)метил]-4,7-диоксо-8-({ 6-[3-(пиперазин-1-ил)азетидин-1-ил]пиридин-2-ил} метил)-2-(проп-2-ен-1-ил)-октагидро-1h-пиразино[2,1-c][1,2,4]триазин-1-карбоксамидное соединение | |
JP2001502297A (ja) | 医薬用化合物 | |
US8916573B2 (en) | Quinazoline-2,4-dione derivatives | |
SA519402422B1 (ar) | مركبات 2-أريل غير متجانس-3-أكسو-2، 3-ثنائي هيدرو بيريدازين-4-كربوكساميد لمعالجة السرطان | |
US6680311B1 (en) | Cryptophycin compounds | |
SK50793A3 (en) | Method for preparing taxane derivatives, novel derivatives thereby obtained and pharmaceutical compositions containing same | |
KR20090097210A (ko) | 키네신 방추체 단백질 (eg-5) 억제제로서의 이미다졸 유도체 | |
JP4181632B2 (ja) | 新規合成クリプトフィシン類 | |
NZ713233A (en) | Methods and compositions for the treatment and/or prophylaxis of clostridium difficile associated disease | |
SK572004A3 (en) | New derivatives of oxazolidinones as antibacterial agents | |
KR20070095944A (ko) | Bace 억제제로서 유용한 마크로시클릭 화합물 및조성물 | |
JP5662940B2 (ja) | 新規な抗微生物薬 | |
CA3080116A1 (fr) | Derives macrocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
JP2001500853A (ja) | 医薬化合物 | |
WO2003070166A2 (en) | Novel tyloindicines and related processes, pharmaceutical compositions and methods | |
US20020128185A1 (en) | Pharmaceutical compounds | |
JP2002510625A (ja) | Mrp1の阻害方法 | |
JP2000502351A (ja) | 医薬化合物 | |
US6673809B2 (en) | Tricyclic compounds as MRP1-inhibitors | |
Kishore et al. | Synthesis and antimicrobial activity of benzimidazolyl oxazolyl thiazolidin-4-ones and azetidin-2-ones | |
JP6616525B2 (ja) | Bace1阻害剤 | |
JPH09508917A (ja) | フェニルピロール誘導体およびそのドーパミンd▲下3▼アンタゴニストとしての使用 | |
MXPA98001604A (en) | Farmaceuti compounds |